These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7326408)

  • 1. [Formation of a generator of pathologically enhanced excitation in the caudate nucleus in experimental parkinsonism].
    Aliev MN; Igon'kina SI; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1981 Dec; 92(12):657-9. PubMed ID: 7326408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parkinson syndrome after administration of acetylcholine into the caudate nuclei].
    Kryzhanovskiĭ GN; Atadzhanov MA; Voronina TA; Nerobkova LN
    Biull Eksp Biol Med; 1989 May; 107(5):522-5. PubMed ID: 2736276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of difenin on experimental parkinsonian syndrome].
    Kryzhanovskiĭ GN; Atadzhanov MA; Kucherianu VG
    Biull Eksp Biol Med; 1990 Sep; 110(9):242-4. PubMed ID: 2268704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EEG changes and symptomatic parkinsonism after intracaudate administration of dopamine antibodies].
    Kryzhanovskiĭ GN; Atadzhanov MA; Magaeva SV; Basharova LA; Vetrilé LA
    Biull Eksp Biol Med; 1989 Jan; 107(1):13-6. PubMed ID: 2914165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Appearance of parkinsonian syndrome after administration of delta sleep-inducing peptide into the rat substantia nigra].
    Kryzhanovskiĭ GN; Shandra AA; Godlevskiĭ LS; Mikhaleva II
    Biull Eksp Biol Med; 1990 Feb; 109(2):119-21. PubMed ID: 2337637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of substance P on experimental parkinsonian syndrome].
    Kryzhanovskiĭ GN; Atadzhanov MA; Kucherianu VG
    Biull Eksp Biol Med; 1989 Oct; 108(10):404-7. PubMed ID: 2480824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modelling of the parkinsonian syndrome by the administration of kainic acid into the caudate nucleus].
    Kryzhanovskiĭ GN; Makul'kin RF; Shandra AA; Godlevskiĭ LS; Rozhkov VS
    Biull Eksp Biol Med; 1987 Jun; 103(6):650-3. PubMed ID: 3593943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of intranasally administered substance P in parkinsonian syndrome].
    Kryzhanovskiĭ GN; Kucherianu VG; Godlevskiĭ LS; Mazarati AD
    Biull Eksp Biol Med; 1992 Jan; 113(1):16-9. PubMed ID: 1382692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The characteristics of a parkinsonian syndrome induced in an experiment by a deficiency of nigrostriatal dopamine and by stimulation of the cholinergic neurons of the caudate nucleus].
    Kryzhanovskiĭ GN; Atadzhanov MA; Voronina TA; Nerobkova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(6):3-7. PubMed ID: 8160497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the striatal serotoninergic apparatus in Parkinsonian syndrome].
    Kryzanovskiĭ GN; Magaeva SV; Trekova NA; Vetrilé LA; Basharova LA; Atadzhanov MA
    Biull Eksp Biol Med; 1993 May; 115(5):466-9. PubMed ID: 8043821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of galanin on the experimental parkinsonian syndrome in rats induced by the intrastriatal administration of kainic acid].
    Shandra AA; Mazarati AM; Servetskiĭ KL; Kresiun VI
    Biull Eksp Biol Med; 1993 Aug; 116(8):123-5. PubMed ID: 7506070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental stereotypy caused by disorders of GABA-ergic mechanisms in the caudate nuclei].
    Aliev MN; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1979 Apr; 87(4):314-7. PubMed ID: 571293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental vestibulopathy produced as a result of formation of a generator of pathologically enhanced excitation in the vestibular nuclei (phenomenon of a determinative dispatch station)].
    Kryzhanovskiĭ GN; Rekhtman MB; Konnikov BA; Sheĭkhon FD
    Biull Eksp Biol Med; 1976 Feb; 81(2):147-50. PubMed ID: 1276401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dopamine antibodies in the pathogenesis of parkinsonism].
    Kryzhanovskiĭ GN; Evseev VA; Magaeva SV; Trekova NA; Vetrilé LA; Man'kovskiĭ NB; Karaban' IN
    Biull Eksp Biol Med; 1991 Nov; 112(11):470-2. PubMed ID: 1725756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in electric activity of neurons of dorsal raphe nuclei in the development of generator of pathologically enhanced excitation in the nociceptive system].
    Kryzhanovskiĭ GN; Igon'kina SI; Trubetskaia VV
    Biull Eksp Biol Med; 1990 Dec; 110(12):573-6. PubMed ID: 2083351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental neuropathological syndromes during the development of hyperactive determinant dispatch stations in the caudate nuclei].
    Kryzhanovskiĭ GN; Aliev MN
    Biull Eksp Biol Med; 1976; 81(4):397-9. PubMed ID: 945093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-electroencephalographic indices of the parkinsonian syndrome induced by MPP+ in rats].
    Kryzhanovski? GN; Atadzhanov MA; Voronina TA; Nerobkova LN; Zagorevski VA
    Biull Eksp Biol Med; 1989 Feb; 107(2):147-50. PubMed ID: 2784332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age characteristics of the development of a reserpine model of parkinsonism in rats].
    Rushkevich IuE
    Biull Eksp Biol Med; 1987 Dec; 104(12):654-7. PubMed ID: 3689952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal mechanism underlying parkinsonism and dyskinesia, and differential roles of the putamen and caudate nucleus.
    Yoshida M
    Adv Neurol; 1993; 60():71-7. PubMed ID: 8380531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modeling parkinsonism (review)].
    Atadzhanov M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):110-9. PubMed ID: 6805182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.